Shady Adnan Awad

机构：University of Helsinki, Cairo University, Helsinki University Hospital, MRC Weatherall Institute of Molecular Medicine, MRC Human Immunology Unit, Oxford BioMedica (United Kingdom) · ORCID：0000-0001-6205-7799

发表论文 48 篇 · 总被引 970 次 · h-index 15

代表论文

• Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia (2022 · Blood · 被引 130)
• Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets (2020 · Leukemia · 被引 74)
• Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation (2023 · Leukemia · 被引 58)
• Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia (2021 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 36)
• Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation (2022 · Blood Cancer Journal · 被引 25)
• IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer (2022 · Frontiers in Immunology · 被引 23)